Literature DB >> 27800119

Updates on Psoriasis and Cutaneous Oncology: Proceedings from the 2016 MauiDerm Meeting based on presentations by.

George Martin, Bruce E Strober, Craig L Leonardi, Joel M Gelfand, Andrew Blauvelt, Arthur Kavanaugh, Linda Stein Gold, Brian Berman, Ted Rosen, Eggert Stockfleth.   

Abstract

Entities:  

Year:  2016        PMID： 27800119      PMCID： PMC5077303     

Source DB:  PubMed          Journal:  J Clin Aesthet Dermatol        ISSN： 1941-2789


× No keyword cloud information.
  135 in total

1.  A Phase 2 Trial of Guselkumab versus Adalimumab for Plaque Psoriasis.

Authors:  Kenneth B Gordon; Kristina Callis Duffin; Robert Bissonnette; Jörg C Prinz; Yasmine Wasfi; Shu Li; Yaung-Kaung Shen; Philippe Szapary; Bruce Randazzo; Kristian Reich
Journal:  N Engl J Med       Date:  2015-07-09       Impact factor: 91.245

2.  Tildrakizumab (MK-3222), an anti-interleukin-23p19 monoclonal antibody, improves psoriasis in a phase IIb randomized placebo-controlled trial.

Authors:  K Papp; D Thaçi; K Reich; E Riedl; R G Langley; J G Krueger; A B Gottlieb; H Nakagawa; E P Bowman; A Mehta; Q Li; Y Zhou; R Shames
Journal:  Br J Dermatol       Date:  2015-10-15       Impact factor: 9.302

Review 3.  Novel psoriasis therapies and patient outcomes, part 1: topical medications.

Authors:  Meghan A Feely; Barry L Smith; Jeffrey M Weinberg
Journal:  Cutis       Date:  2015-03

4.  Psoriasis and Inflammatory Bowel Disease: Two Sides of the Same Coin?

Authors:  Gionata Fiorino; Paolo D Omodei
Journal:  J Crohns Colitis       Date:  2015-06-15       Impact factor: 9.071

Review 5.  When does a difference make a difference? Interpretation of number needed to treat, number needed to harm, and likelihood to be helped or harmed.

Authors:  L Citrome; T A Ketter
Journal:  Int J Clin Pract       Date:  2013-05       Impact factor: 2.503

6.  Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use.

Authors:  A Y Finlay; G K Khan
Journal:  Clin Exp Dermatol       Date:  1994-05       Impact factor: 3.470

7.  Psoriasis Epidemiology Screening Tool (PEST): a report from the GRAPPA 2009 annual meeting.

Authors:  Philip S Helliwell
Journal:  J Rheumatol       Date:  2011-03       Impact factor: 4.666

8.  Medical comorbidity associated with psoriasis in adults: a population-based study.

Authors:  Y-W Yang; J J Keller; H-C Lin
Journal:  Br J Dermatol       Date:  2011-09-29       Impact factor: 9.302

9.  Attributable risk estimate of severe psoriasis on major cardiovascular events.

Authors:  Nehal N Mehta; YiDing Yu; Rebecca Pinnelas; Parasuram Krishnamoorthy; Daniel B Shin; Andrea B Troxel; Joel M Gelfand
Journal:  Am J Med       Date:  2011-08       Impact factor: 4.965

10.  Expanding the psoriasis disease profile: interrogation of the skin and serum of patients with moderate-to-severe psoriasis.

Authors:  Mayte Suárez-Fariñas; Katherine Li; Judilyn Fuentes-Duculan; Karen Hayden; Carrie Brodmerkel; James G Krueger
Journal:  J Invest Dermatol       Date:  2012-07-05       Impact factor: 8.551
View more
  2 in total

Review 1.  Psoriasis and Psoriatic Arthritis.

Authors:  Jennifer Clay Cather; Melodie Young; Martin Jan Bergman
Journal:  J Clin Aesthet Dermatol       Date:  2017-03-01

2.  Mergeomics 2.0: a web server for multi-omics data integration to elucidate disease networks and predict therapeutics.

Authors:  Jessica Ding; Montgomery Blencowe; Thien Nghiem; Sung-Min Ha; Yen-Wei Chen; Gaoyan Li; Xia Yang
Journal:  Nucleic Acids Res       Date:  2021-07-02       Impact factor: 16.971
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.